ALPN
Alpine Immune Sciences Inc
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
26 hedge funds and large institutions have $21.1M invested in Alpine Immune Sciences Inc in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.88M | |
| 2 | +$203K | |
| 3 | +$71.9K | |
| 4 |
Morgan Stanley
New York
|
+$45.6K |
| 5 |
Renaissance Technologies
New York
|
+$35K |
Top Sellers
| 1 | -$429K | |
| 2 | -$219K | |
| 3 | -$177K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$169K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$96.8K |